AssetMark Inc’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

AssetMark Inc’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-12	Closed	-$1K	–	1355
2016 Q1	$1K	Sell	12 -4	-25%	-$295	﹤0.01%	1158
2015 Q4	$2K	Buy	+16	New	+$1.76K	﹤0.01%	1155

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

AssetMark Inc's ANAC Position: Q2 2016 in Review

AssetMark Inc sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 12 shares — an estimated $1K sold.

AssetMark Inc first reported a position in ANAC in Q4 2015 and held it in 2 quarters. The position peaked at $2K in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

AssetMark Inc reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
AssetMark Inc sold 12 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $1K.
AssetMark Inc first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2015 and held it in 2 quarters.
AssetMark Inc's ANACOR PHARMACEUTICALS INC COM position peaked at $2K in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on AssetMark Inc's 13F filing for Q2 2016, filed 8 Aug 2016.